{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T14:40:01Z","timestamp":1729176001861,"version":"3.27.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00393-024-01518-7","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T15:04:16Z","timestamp":1716303856000},"page":"629-633","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Head-to-head-Studien zur R\u00f6ntgenprogression bei axialer Spondyloarthritis","Head-to-head studies on radiographic progression in axial spondyloarthritis"],"prefix":"10.1007","volume":"83","author":[{"given":"Uta","family":"Kiltz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildrun","family":"Haibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"issue":"1","key":"1518_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro\u00a0S, Nikiphorou\u00a0E, Sepriano\u00a0A et\u00a0al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19\u201334","journal-title":"Ann Rheum Dis"},{"issue":"10089","key":"1518_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper\u00a0J, Poddubnyy\u00a0D (2017) Axial spondyloarthritis. Lancet 390(10089):73\u201384","journal-title":"Lancet"},{"key":"1518_CR3","volume-title":"Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a\u00a0systematic literature review and network meta-analysis. Rheumatology","author":"A Deodhar","year":"2023","unstructured":"Deodhar\u00a0A, Machado\u00a0PM, Morup\u00a0M et\u00a0al (2023) Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a\u00a0systematic literature review and network meta-analysis. Rheumatology. Oxford"},{"key":"1518_CR4","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1002\/art.42282","volume":"74","author":"X Baraliakos","year":"2022","unstructured":"Baraliakos\u00a0X, Ostergaard\u00a0M, Poddubnyy\u00a0D et\u00a0al (2022) Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis: A\u00a0Randomized Phase\u00a0IIIb Study. Arthritis Rheumatol 74:4564\u20134566","journal-title":"Arthritis Rheumatol"},{"key":"1518_CR5","doi-asserted-by":"crossref","unstructured":"Proft F, Torgutalp M, Muche B et\u00a0al (2024) Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2\u00a0years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Ann Rheum Dis","DOI":"10.1136\/ard-2023-224699"},{"issue":"4","key":"1518_CR6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/ard.2010.139667","volume":"70","author":"IH Song","year":"2011","unstructured":"Song\u00a0IH, Hermann\u00a0K, Haibel\u00a0H et\u00a0al (2011) Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a\u00a048-week randomised controlled trial. Ann Rheum Dis 70(4):590\u2013596","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1518_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/annrheumdis-2012-203201","volume":"73","author":"J Sieper","year":"2014","unstructured":"Sieper\u00a0J, Lenaerts\u00a0J, Wollenhaupt\u00a0J et\u00a0al (2014) Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1. Ann Rheum Dis 73(1):101\u2013107 (Jan)","journal-title":"Ann Rheum Dis"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01518-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-024-01518-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01518-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T11:04:06Z","timestamp":1729076646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-024-01518-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1518"],"URL":"https:\/\/doi.org\/10.1007\/s00393-024-01518-7","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"assertion":[{"value":"15 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Kiltz und H.\u00a0Haibel geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autorinnen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}